|
|
Novozymes Biopharma | Albumin fusion
Description: Our proprietary technology allows the molecular fusion of albumin to protein drug candidates for improved half-life and bioavailability. Albumin fusion technology is a natural alternative to PEGylation.
Keywords: albumin fusion, albufuse, half-life extension.
Tags:
albufuse,
biopharma,
fusion,
albumin,
novozymes,
life,
half,
expression,
technology,
extension,
acid,
purification,
factors,
ralbumin,
ligands,
platforms,
growth,
presentations,
legal,
disclaimer,
sitemap,
contact,
datasheets,
articles,
brochures,
transferrin,
hyaluronic,
home,
events,
technologies,
products,
applications,
news,
resources,
candidates,
molecular,
protein,
improved,
drug,
natural,
Albufuse.com
Content Revalency:
Title: 80.00%
Description: 62.50%
Keywords: 83.33% | Document size: 7,446 bytes
More info:
Whois -
Trace Route -
RBL Check
| ALBUFUSE.COM - Site Location |
| Country/Flag |
 United States |
| City/Region/Zip Code |
Reston, VA, 20190 |
| Organization |
VeriSign Infrastructure & Operations |
| Internet Service Provider |
VeriSign Infrastructure & Operations |
|
ALBUFUSE.COM - Domain Information |
| Domain |
ALBUFUSE.COM [ Traceroute RBL/DNSBL lookup ] |
| Registrar |
CSC Corporate Domains, Inc. CSC CORPORATE DOMAINS, INC. |
| Whois server |
whois.verisign-grs.com |
| Created |
29-Nov-2017 |
| Updated |
25-Nov-2018 |
| Expires |
29-Nov-2019 |
| Time Left |
0 days 0 hours 0 minutes |
| Status |
clientTransferProhibited https://icann.org/epp#clientTransferProhibited clientTransferProhibited http://www.icann.org/epp#clientTransferProhibited |
| DNS servers |
DNS1.CSCDNS.NET 165.160.12.20
DNS2.CSCDNS.NET 165.160.14.20
dns1.cscdns.net 165.160.12.20
dns2.cscdns.net 165.160.14.20
|
| Site Response Header |
| Response |
HTTP/1.1 302 Moved Temporarily |
| Server |
Microsoft-IIS/7.0 |
| Date |
Thu, 07 Apr 2011 16:19:14 GMT |
| Content-Type |
text/html; charset=utf-8 |
| Cookie |
Favorites=; expires=Fri, 03-Jul-2037 22:00:00 GMT; path=/; HttpOnly |
|
